90 related articles for article (PubMed ID: 38606998)
21. The role of Exosomes in the Pathogenesis of Nasopharyngeal Carcinoma and the involved Clinical Application.
Luo H; Yi B
Int J Biol Sci; 2021; 17(9):2147-2156. PubMed ID: 34239345
[TBL] [Abstract][Full Text] [Related]
22. Combination of Epithelial Growth Factor Receptor Blockers and CDK4/6 Inhibitor for Nasopharyngeal Carcinoma Treatment.
Li HP; Huang CY; Lui KW; Chao YK; Yeh CN; Lee LY; Huang Y; Lin TL; Kuo YC; Huang MY; Lai YR; Yeh YM; Fan HC; Lin AC; Hsieh JC; Chang KP; Lin CY; Wang HM; Chang YS; Hsu CL
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34204797
[TBL] [Abstract][Full Text] [Related]
23. CRISPR/Cas9-mediated double knockout of SRPK1 and SRPK2 in a nasopharyngeal carcinoma cell line.
Prattapong P; Ngernsombat C; Aimjongjun S; Janvilisri T
Cancer Rep (Hoboken); 2020 Apr; 3(2):e1224. PubMed ID: 32671994
[TBL] [Abstract][Full Text] [Related]
24. Nasopharyngeal carcinoma.
Chen YP; Chan ATC; Le QT; Blanchard P; Sun Y; Ma J
Lancet; 2019 Jul; 394(10192):64-80. PubMed ID: 31178151
[TBL] [Abstract][Full Text] [Related]
25. Establishment and characterization of new tumor xenografts and cancer cell lines from EBV-positive nasopharyngeal carcinoma.
Lin W; Yip YL; Jia L; Deng W; Zheng H; Dai W; Ko JMY; Lo KW; Chung GTY; Yip KY; Lee SD; Kwan JS; Zhang J; Liu T; Chan JY; Kwong DL; Lee VH; Nicholls JM; Busson P; Liu X; Chiang AKS; Hui KF; Kwok H; Cheung ST; Cheung YC; Chan CK; Li B; Cheung AL; Hau PM; Zhou Y; Tsang CM; Middeldorp J; Chen H; Lung ML; Tsao SW
Nat Commun; 2018 Nov; 9(1):4663. PubMed ID: 30405107
[TBL] [Abstract][Full Text] [Related]
26. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Bray F; Ferlay J; Soerjomataram I; Siegel RL; Torre LA; Jemal A
CA Cancer J Clin; 2018 Nov; 68(6):394-424. PubMed ID: 30207593
[TBL] [Abstract][Full Text] [Related]
27. Establishment of a nasopharyngeal carcinoma cell line capable of undergoing lytic Epstein-Barr virus reactivation.
Yip YL; Lin W; Deng W; Jia L; Lo KW; Busson P; Vérillaud B; Liu X; Tsang CM; Lung ML; Tsao SW
Lab Invest; 2018 Aug; 98(8):1093-1104. PubMed ID: 29769697
[TBL] [Abstract][Full Text] [Related]
28. Progression of understanding for the role of Epstein-Barr virus and management of nasopharyngeal carcinoma.
Nakanishi Y; Wakisaka N; Kondo S; Endo K; Sugimoto H; Hatano M; Ueno T; Ishikawa K; Yoshizaki T
Cancer Metastasis Rev; 2017 Sep; 36(3):435-447. PubMed ID: 28819752
[TBL] [Abstract][Full Text] [Related]
29. Widespread Use of Misidentified Cell Line KB (HeLa): Incorrect Attribution and Its Impact Revealed through Mining the Scientific Literature.
Vaughan L; Glänzel W; Korch C; Capes-Davis A
Cancer Res; 2017 Jun; 77(11):2784-2788. PubMed ID: 28455420
[TBL] [Abstract][Full Text] [Related]
30. Are your results valid? Cellular authentication a need from the past, an emergency on the present.
Cosme B; Falagan-Lotsch P; Ribeiro M; Napoleão K; Granjeiro JM; Moura-Neto R
In Vitro Cell Dev Biol Anim; 2017 May; 53(5):430-434. PubMed ID: 28127703
[TBL] [Abstract][Full Text] [Related]
31. Standards for Cell Line Authentication and Beyond.
Almeida JL; Cole KD; Plant AL
PLoS Biol; 2016 Jun; 14(6):e1002476. PubMed ID: 27300367
[TBL] [Abstract][Full Text] [Related]
32. Cancer statistics in China, 2015.
Chen W; Zheng R; Baade PD; Zhang S; Zeng H; Bray F; Jemal A; Yu XQ; He J
CA Cancer J Clin; 2016; 66(2):115-32. PubMed ID: 26808342
[TBL] [Abstract][Full Text] [Related]
33. Genetic profiling reveals an alarming rate of cross-contamination among human cell lines used in China.
Ye F; Chen C; Qin J; Liu J; Zheng C
FASEB J; 2015 Oct; 29(10):4268-72. PubMed ID: 26116706
[TBL] [Abstract][Full Text] [Related]
34. The future of forensic DNA analysis.
Butler JM
Philos Trans R Soc Lond B Biol Sci; 2015 Aug; 370(1674):. PubMed ID: 26101278
[TBL] [Abstract][Full Text] [Related]
35. Discovery of HeLa Cell Contamination in HES Cells: Call for Cell Line Authentication in Reproductive Biology Research.
Kniss DA; Summerfield TL
Reprod Sci; 2014 Aug; 21(8):1015-1019. PubMed ID: 24520087
[TBL] [Abstract][Full Text] [Related]
36. Cyclin D1 overexpression supports stable EBV infection in nasopharyngeal epithelial cells.
Tsang CM; Yip YL; Lo KW; Deng W; To KF; Hau PM; Lau VM; Takada K; Lui VW; Lung ML; Chen H; Zeng M; Middeldorp JM; Cheung AL; Tsao SW
Proc Natl Acad Sci U S A; 2012 Dec; 109(50):E3473-82. PubMed ID: 23161911
[TBL] [Abstract][Full Text] [Related]
37. Establishment and characterization of a novel nasopharyngeal carcinoma cell line (SUNE2) from a Cantonese patient.
Dong JQ; Li MZ; Liu ZG; Zhong Q; Xiong D; Xu LH; Du Y; Xia YF; Zeng MS
Chin J Cancer; 2012 Jan; 31(1):36-44. PubMed ID: 22176775
[TBL] [Abstract][Full Text] [Related]
38. [Relationship between the insulin-like growth factor 1 receptor signaling pathway and the resistance of nasopharyngeal carcinoma to cetuximab].
Zuo Q; Luo RC
Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):575-9. PubMed ID: 21122407
[TBL] [Abstract][Full Text] [Related]
39. Cell line misidentification: the beginning of the end.
American Type Culture Collection Standards Development Organization Workgroup ASN-0002
Nat Rev Cancer; 2010 Jun; 10(6):441-8. PubMed ID: 20448633
[TBL] [Abstract][Full Text] [Related]
40. Identification of biomarkers for predicting nasopharyngeal carcinoma response to radiotherapy by proteomics.
Feng XP; Yi H; Li MY; Li XH; Yi B; Zhang PF; Li C; Peng F; Tang CE; Li JL; Chen ZC; Xiao ZQ
Cancer Res; 2010 May; 70(9):3450-62. PubMed ID: 20406978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
